HORIZON-HLTH-2027-02-DISEASE-01-two-stage Contribution

As Doğuş Teknoloji, we can contribute by developing interoperable and ethically sound digital tools that support and enhance the methods and interventions developed within the project for the management and treatment of non‑communicable diseases. These digital solutions may include AI‑enabled platforms, clinician‑ and patient‑facing applications, and data integration layers that facilitate monitoring of disease progression, intervention adherence, and long‑term efficacy in both clinical trial settings and real‑world conditions. Designed to leverage existing health data infrastructures and comply with FAIR data principles, the tools can integrate multimodal data from wearables, clinical assessments, and electronic health records to generate actionable insights for researchers and clinicians. By enabling continuous patient engagement, supporting evidence generation for late‑stage clinical validation, and facilitating scalability and sustainability through real‑world data analysis and health‑economic assessments, these digital instruments will strengthen the impact and uptake of innovative healthcare interventions targeting cardiovascular diseases, diabetes, chronic respiratory diseases, and chronic kidney diseases.

 We can satisfy the below scope/outcomes of the call:
-  Use and/or develop technologies, including digital ones (e.g. (generative) Artificial Intelligence, wearable technologies) to help implement and monitor the long-term efficacy of the intervention(s), as well as manage the disease and/or monitor their progression (e.g. with unobtrusive technologies suitable for patient monitoring at home and in real-world conditions), whilst also ensuring they are bias-free, inclusive, and ethically sound. Hardware and software should be interoperable in line with internationally accepted standards. The use of virtual human twins could also be considered, where relevant.